NHS National Framework Agreement for the emergency supply of Generic Pharmaceuticals - Co-Amoxiclav powder for solution (for DLN and DNW Regions only)
key details
| Value | £1,400,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33690000 |
| Region | North West, East of England, London |
| Deadline | 12 Jun 2015 |
| Contract start | 24 Aug 2015 |
| Contract end | 30 Jun 2016 |
| SME suitable | Yes |
| OCID | ocds-b5fd17-a24157d5-adc8-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GlaxoSmithKline UK Limited | £0 | 17 Jun 2015 | active |
description
NHS Framework for the emergency supply of Generic Pharmaceuticals - Co-Amoxiclav powder for solution.
Period of framework agreement - 24/08/2015 to 30/06/2016
Regions - DLN and DNW
Additional information: The previous contractor terminated their agreement indicating an inability to supply. This tender sought to put in place arrangements to assure continuity of supply of this medicine.
The value of the framework agreement will be in the range of £1,150,000 and £1,400,000
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Aug 2015 | Award (award) | · | ocds-b5fd17-a24157d5-adc8-11e6-9901-0019b9f3037b-70631-cm-phg-15-5468 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
- Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
- Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
- Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
- Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
- Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
- Controlled drugs · London Ambulance Service NHS Trust · £154,225
- IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.